PHARMACOKINETICS
Clinical trials for PHARMACOKINETICS explained in plain language.
Never miss a new study
Get alerted when new PHARMACOKINETICS trials appear
Sign up with your email to follow new studies for PHARMACOKINETICS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill shows promise in early trial for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests an experimental oral drug called IPG7236 in people with advanced solid tumors that have spread or cannot be removed. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. About 196 adults will take the drug twi…
Matched conditions: PHARMACOKINETICS
Phase: PHASE1, PHASE2 • Sponsor: Nanjing Immunophage Biotech Co., Ltd • Aim: Disease control
Last updated Apr 28, 2026 13:14 UTC
-
New inhaled drug RCS-21 put to the test in healthy volunteers
Knowledge-focused Recruiting nowThis early-stage study tests whether a single inhaled dose of RCS-21 is safe and tolerable in 24 healthy adults aged 18 to 64. Participants receive one dose and are closely monitored for side effects. The study does not aim to treat any disease, but to gather important safety inf…
Matched conditions: PHARMACOKINETICS
Phase: PHASE1 • Sponsor: RNATICS GmbH • Aim: Knowledge-focused
Last updated May 01, 2026 15:57 UTC
-
New study tracks antifungal drug in critically ill kids
Knowledge-focused Recruiting nowThis study looks at how the antifungal medicine caspofungin behaves in children with severe infections, especially those with liver problems or on life support like ECMO. Researchers will measure drug levels in the blood to understand how the body processes it. The goal is to imp…
Matched conditions: PHARMACOKINETICS
Sponsor: Children's Hospital of Fudan University • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:50 UTC
-
Study aims to perfect antibiotic dosing for kids on ECMO
Knowledge-focused Recruiting nowThis study looks at how antibiotics work in the bodies of critically ill newborns, infants, and children who are on a heart-lung machine called ECMO. The goal is to see if current doses are effective or if adjustments are needed to fight infections better. Researchers will monito…
Matched conditions: PHARMACOKINETICS
Phase: NA • Sponsor: University Hospital, Ghent • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:50 UTC